STAT5b mutations, N642H and Y665F, have also been found to be gain-of-function mutations in the SH2 domain and were initially discovered in a small percentage of clinically aggressive CD8+ T-LGLL (47). The gene discussed is CD8A; the disease is T-cell large granular lymphocyte leukemia.